A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination—when
New avenue for study of diseases like multiple sclerosis
Study identifies reactive neuroinflammatory astrocyte subtypes in the mouse brain
Astrocytes are a specialized class of glial cells highly abundant in the central nervous system (CNS) of humans and other
Study: Individuals with primary care physician continuity have better cancer survival
Research led by scientists at the University of South Carolina’s Arnold School of Public Health, Yale University School of Medicine
Study reveals neuroendocrine tumor mortality patterns to inform treatment decisions
Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of
Study highlights steep rise in cardiac arrests associated with opioid use
A nationwide US study has shown that the rate of opioid-related cardiac arrests has steeply risen and is now on
Study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did
New study reveals patients from minority ethnic groups are more likely to be admitted to hospital
Patients from minority ethnic groups have a disproportionately higher rate of emergency hospital admissions, according to research by Queen Mary
Study highlights ‘vital 30-day window’ for hospital inpatients to get COVID-19 jab
A new study published today has highlighted a “30-day window” for hospital inpatients to be vaccinated against COVID-19 to help
Study shows cannabis terpenes provide pain relief, contribute to entourage effect
When it comes to the medicinal and therapeutic properties of Cannabis sativa, an unsolved mystery is whether there exists an
Study finds lower antibody activity against delta variant at single vaccine dose, but vaccines still work
Chris Whitty, the chief medical officer for England, recently announced that the delta variant is no longer of concern because